Page last updated: 2024-08-21

isoxazoles and lc15-0444

isoxazoles has been researched along with lc15-0444 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Choi, MG; Ihm, SH; Kang, JG; Kim, CS; Kim, SH; Lee, SJ; Yoo, HJ	1

Other Studies

1 other study(ies) available for isoxazoles and lc15-0444

Article	Year
The dipeptidyl peptidase-IV inhibitor gemigliptin alone or in combination with NVP-AUY922 has a cytotoxic activity in thyroid carcinoma cells. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2017, Volume: 39, Issue:10 Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Carcinoma; Cell Line, Tumor; Cell Survival; Dipeptidyl-Peptidase IV Inhibitors; Drug Synergism; Flow Cytometry; Humans; Isoxazoles; Piperidones; Pyrimidines; Resorcinols; Signal Transduction; Thyroid Neoplasms	2017

Article

Year

The dipeptidyl peptidase-IV inhibitor gemigliptin alone or in combination with NVP-AUY922 has a cytotoxic activity in thyroid carcinoma cells.

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2017, Volume: 39, Issue:10

Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Carcinoma; Cell Line, Tumor; Cell Survival; Dipeptidyl-Peptidase IV Inhibitors; Drug Synergism; Flow Cytometry; Humans; Isoxazoles; Piperidones; Pyrimidines; Resorcinols; Signal Transduction; Thyroid Neoplasms

2017